|
To maximise value for our customers, we have focused on efficiently manufacturing high-quality, large-volume products.
Sunaka is one of the few companies in the world to be present across the pharmaceutical manufacturing value chain starting from Active Pharmaceutical Ingredients (APIs) through Pharmaceutical Formulation Intermediates (PFIs) to Finished Dosages (FDs). We offer our customers all three components of the pharmaceutical manufacturing value chain to enhance flexibility and efficiency.
We back our product lines with world-class, large-scale manufacturing infrastructure. Our facility in Gagillapur has the world’s largest PFI capacity along with an industry-leading batch size of six tons. In addition, the Gagillapur facility has one of the largest single-site Finished Dosage capacities in the world for their respective products. Our top-of-the-line Jeedimetla and Bonthapally facilities are equally impressive and are among the largest single-site capacities in the world for their respective products. To support our Ibuprofen customers, we formed a JV with Hubei Biocause in Wuhan, China, a premier Ibuprofen manufacturer.
All our facilities meet the stringent requirements of demanding international regulatory authorities such as the U.S. FDA, MHRA, EDQM and the Australian TGA.
|
